Table 2.
Country | Regulations | Prescription/Non-prescription (Melatonin) | Comments |
---|---|---|---|
United States | Considers all supplements safe until proven unsafe. Not regulated prior to market availability. | Non-prescription dietary supplement | FDA not required to test new ingredients/supplements in clinical trials. |
Canada | Medications fall under the Food and Drug Regulations issued by the Canadian Government25 | Non-prescription health product | Must contain Natural Product Number. |
European Union | Medications are regulated through the European Regulatory Network, which consists of 50 regulatory authorities from across Europe26 | Prescription for sustained release; less than 2 mg immediate release has variable status based on country | European Medicines Agency has set specific guidelines for use. Some countries, such as Poland, consider melatonin non-prescription |
Non-European Union Countries in Europe (Norway) | Medications are regulated by the Norwegian Medicines Agency27 | Prescription27 | |
United Kingdom | Follows the European Union Guidelines | Prescription | |
Taiwan | Medications are regulated under the Pharmaceutical Affairs Act | Controlled-substance |